Northern Trust’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-287,968
Closed -$29.4M 4547
2023
Q2
$29.4M Buy
287,968
+5,120
+2% +$522K 0.01% 1327
2023
Q1
$25.7M Buy
282,848
+10,957
+4% +$996K 0.01% 1389
2022
Q4
$10.3M Buy
271,891
+13,498
+5% +$513K ﹤0.01% 1985
2022
Q3
$6.49M Sell
258,393
-2,512
-1% -$63.1K ﹤0.01% 2294
2022
Q2
$7.93M Sell
260,905
-7,650
-3% -$232K ﹤0.01% 2201
2022
Q1
$8.8M Sell
268,555
-7,625
-3% -$250K ﹤0.01% 2225
2021
Q4
$7.28M Sell
276,180
-148
-0.1% -$3.9K ﹤0.01% 2461
2021
Q3
$27.8M Sell
276,328
-12,768
-4% -$1.28M ﹤0.01% 1545
2021
Q2
$40.9M Buy
289,096
+157,277
+119% +$22.3M 0.01% 1300
2021
Q1
$13.1M Buy
131,819
+6,639
+5% +$662K ﹤0.01% 2112
2020
Q4
$15.5M Buy
125,180
+4,718
+4% +$583K ﹤0.01% 1972
2020
Q3
$11.7M Sell
120,462
-9,412
-7% -$917K ﹤0.01% 2011
2020
Q2
$20.3M Sell
129,874
-157,000
-55% -$24.5M ﹤0.01% 1612
2020
Q1
$41.4M Buy
286,874
+6,528
+2% +$942K 0.01% 872
2019
Q4
$57.3M Buy
280,346
+19,143
+7% +$3.91M 0.01% 922
2019
Q3
$21M Buy
261,203
+26,351
+11% +$2.12M 0.01% 1653
2019
Q2
$22.2M Buy
234,852
+2,290
+1% +$216K 0.01% 1613
2019
Q1
$19.9M Buy
232,562
+3,880
+2% +$332K ﹤0.01% 1693
2018
Q4
$12.8M Sell
228,682
-3,809
-2% -$214K ﹤0.01% 1901
2018
Q3
$19M Buy
232,491
+48,561
+26% +$3.97M ﹤0.01% 1828
2018
Q2
$6.43M Buy
183,930
+53,946
+42% +$1.89M ﹤0.01% 2546
2018
Q1
$2.67M Buy
129,984
+1,735
+1% +$35.6K ﹤0.01% 2957
2017
Q4
$3.63M Sell
128,249
-3,602
-3% -$102K ﹤0.01% 2803
2017
Q3
$4.1M Buy
131,851
+33,805
+34% +$1.05M ﹤0.01% 2750
2017
Q2
$3.1M Buy
98,046
+27,669
+39% +$875K ﹤0.01% 2899
2017
Q1
$1.59M Buy
70,377
+7,271
+12% +$165K ﹤0.01% 3189
2016
Q4
$1.38M Buy
63,106
+1,227
+2% +$26.8K ﹤0.01% 3257
2016
Q3
$1.63M Buy
61,879
+10,239
+20% +$270K ﹤0.01% 3151
2016
Q2
$1.02M Buy
+51,640
New +$1.02M ﹤0.01% 3342